Vitrolife AB (publ) (FRA:VTFN)

Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of EUR 1.84 billion. The enterprise value is 1.92 billion.

Market Cap	1.84B
Enterprise Value	1.92B

Important Dates

The last earnings date was Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	135.42M
Shares Outstanding	n/a
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	62.50%
Float	75.04M

Valuation Ratios

The trailing PE ratio is 46.19 and the forward PE ratio is 34.10.

PE Ratio	46.19
Forward PE	34.10
PS Ratio	5.80
PB Ratio	1.53
P/TBV Ratio	n/a
P/FCF Ratio	35.16
P/OCF Ratio	27.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.03, with an EV/FCF ratio of 36.73.

EV / Earnings	48.25
EV / Sales	5.97
EV / EBITDA	19.03
EV / EBIT	31.58
EV / FCF	36.73

Financial Position

The company has a current ratio of 4.40, with a Debt / Equity ratio of 0.15.

Current Ratio	4.40
Quick Ratio	3.47
Debt / Equity	0.15
Debt / EBITDA	1.82
Debt / FCF	3.46
Interest Coverage	11.43

Financial Efficiency

Return on equity (ROE) is 3.34% and return on invested capital (ROIC) is 2.72%.

Return on Equity (ROE)	3.34%
Return on Assets (ROA)	2.46%
Return on Invested Capital (ROIC)	2.72%
Return on Capital Employed (ROCE)	4.06%
Revenue Per Employee	276,557
Profits Per Employee	34,698
Employee Count	1,169
Asset Turnover	0.21
Inventory Turnover	3.47

Taxes

In the past 12 months, Vitrolife AB has paid 13.21 million in taxes.

Income Tax	13.21M
Effective Tax Rate	24.87%

Stock Price Statistics

The stock price has decreased by -34.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.25%
50-Day Moving Average	12.12
200-Day Moving Average	14.03
Relative Strength Index (RSI)	65.86
Average Volume (20 Days)	180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of EUR 317.21 million and earned 39.80 million in profits. Earnings per share was 0.29.

Revenue	317.21M
Gross Profit	186.87M
Operating Income	59.97M
Pretax Income	53.09M
Net Income	39.80M
EBITDA	95.06M
EBIT	59.97M
Earnings Per Share (EPS)	0.29

Balance Sheet

The company has 100.31 million in cash and 181.08 million in debt, giving a net cash position of -80.77 million.

Cash & Cash Equivalents	100.31M
Total Debt	181.08M
Net Cash	-80.77M
Net Cash Per Share	n/a
Equity (Book Value)	1.20B
Book Value Per Share	8.88
Working Capital	161.45M

Cash Flow

In the last 12 months, operating cash flow was 67.11 million and capital expenditures -14.83 million, giving a free cash flow of 52.28 million.

Operating Cash Flow	67.11M
Capital Expenditures	-14.83M
Free Cash Flow	52.28M
FCF Per Share	n/a

Margins

Gross margin is 58.91%, with operating and profit margins of 18.91% and 12.55%.

Gross Margin	58.91%
Operating Margin	18.91%
Pretax Margin	16.74%
Profit Margin	12.55%
EBITDA Margin	29.97%
EBIT Margin	18.91%
FCF Margin	16.48%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.75%.

Dividend Per Share	0.10
Dividend Yield	0.75%
Dividend Growth (YoY)	17.20%
Years of Dividend Growth	1
Payout Ratio	33.86%
Buyback Yield	-0.07%
Shareholder Yield	0.68%
Earnings Yield	2.16%
FCF Yield	2.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	7